1. Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer
    Weimin Xu et al, 2019, Journal of International Medical Research CrossRef
  2. The role of transcription factor caudal-related homeobox transcription factor 2 in colorectal cancer
    Chin-Chia Wu et al, 2020, Tzu Chi Medical Journal CrossRef
  3. CDX2 alleviates hypoxia‐induced apoptosis and oxidative stress in spermatogenic cells through suppression of reactive oxygen species‐mediated Wnt/β‐catenin pathway
    Weiwei Li et al, 2024, Journal of Applied Toxicology CrossRef
  4. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions
    Shyam S. Mohapatra et al, 2018, Digestive Diseases and Sciences CrossRef
  5. Novel Diagnostic Biomarkers in Colorectal Cancer
    Aneta L. Zygulska et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Biomarkers as Putative Therapeutic Targets in Colorectal Cancer
    Sonali Pal et al, 2021, Colon Cancer Diagnosis and Therapy CrossRef
  7. Hungatella hathewayi impairs the sensitivity of colorectal cancer cells to 5-FU through decreasing CDX2 expression
    Zhi Huang et al, 2023, Human Cell CrossRef
  8. The Effects of Retinoic Acid on the Expression of HNF4α and Cdx-2 Genes in Caco-2 Cells as a Model of Intestinal Barrier
    Mahshad Karambeigi et al, 2023, Scientific Journal of Kurdistan University of Medical Sciences CrossRef
  9. CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors
    Swati Priya et al, 2021, Journal of Cell Science CrossRef
  10. Cancer‐associated fibroblast‐derived exosomal microRNA‐24‐3p enhances colon cancer cell resistance to MTX by down‐regulating CDX2/HEPH axis
    Hong‐Wei Zhang et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
  11. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma
    Lingyan Xiao et al, 2022, Journal of Healthcare Engineering CrossRef
  12. The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice
    Jordi Badia-Ramentol et al, 2023, Cancer Treatment Reviews CrossRef
  13. CDX2 inhibits epithelial–mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression
    Junhui Yu et al, 2021, British Journal of Cancer CrossRef
  14. Polymorphisms of the vitamin D receptor gene (FOKI,CDX2, and GATA) and susceptibility to chronic periodontitis in diabetic and non‐diabetic individuals: A case‐control study
    Roberto C. M. Pinho et al, 2019, Journal of Investigative and Clinical Dentistry CrossRef
  15. Targeted RASSF1A expression inhibits proliferation of HER2‑positive breast cancer cells in vitro
    Sai He et al, 2023, Experimental and Therapeutic Medicine CrossRef
  16. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression
    Junhui Yu et al, 2019, Cell Death & Disease CrossRef
  17. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer
    Yun-shuai Wang et al, 2022, Disease Markers CrossRef